The MDL added 85 new suits in June, bringing the total number of cases to 3,848 as of July 1, 2026
GLP-1 medications can be especially relevant in these cases because they affect appetite and glucose-related pathways
Available from: Ryan JL, Heckler CE, Roscoe JA, et al
First, as a general rule, we focus on systems that have been well-studied, as these are the systems that have been identified and investigated for a long time, allowing us to collect substantial scientific and clinical data
Although cell signaling studies are desirable for further evaluation of SR18 for obvious reasons, as an alternative, the agonistic potential of SR18 was preliminarily evaluated using computational structural biology techniques instead